Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.

Buttorff C, Andersen MS, Riggs KR, Alexander GC.

Health Aff (Millwood). 2015 Mar;34(3):467-76. doi: 10.1377/hlthaff.2014.0615.

PMID:
25732498
2.

Medicare essential: an option to promote better care and curb spending growth.

Davis K, Schoen C, Guterman S.

Health Aff (Millwood). 2013 May;32(5):900-9. doi: 10.1377/hlthaff.2012.1203.

PMID:
23650323
3.

Effect of switching to a high-deductible health plan on use of chronic medications.

Reiss SK, Ross-Degnan D, Zhang F, Soumerai SB, Zaslavsky AM, Wharam JF.

Health Serv Res. 2011 Oct;46(5):1382-401. doi: 10.1111/j.1475-6773.2011.01252.x. Epub 2011 Mar 17.

4.

Does cost sharing really reduce inappropriate prescriptions among the elderly?

Costa Font J, Gemmill Toyama M.

Health Policy. 2011 Jul;101(2):195-208. doi: 10.1016/j.healthpol.2010.09.001. Epub 2010 Oct 2.

PMID:
20889224
5.

The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.

Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, Semmens J.

Pharmacoepidemiol Drug Saf. 2008 Nov;17(11):1091-9. doi: 10.1002/pds.1670.

PMID:
18942671
6.

Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.

Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH.

Am Heart J. 2008 Jul;156(1):31-6. doi: 10.1016/j.ahj.2008.03.021. Epub 2008 Jun 6.

7.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

8.

Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK.

Atella V, Schafheutle E, Noyce P, Hassell K.

Appl Health Econ Health Policy. 2005;4(1):23-35.

PMID:
16076236
10.
12.

Access to medicines: cost as an influence on the views and behaviour of patients.

Schafheutle EI, Hassell K, Noyce PR, Weiss MC.

Health Soc Care Community. 2002 May;10(3):187-95.

PMID:
12121255
13.

Living longer, staying well: promoting good health for older women.

Collins KS, Strumpf E.

Issue Brief (Commonw Fund). 2000 Sep;(412):1-7.

PMID:
11665697
14.

Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, Hurley J, Grad R, Latimer E, Perreault R, McLeod P, Huang A, Larochelle P, Mallet L.

JAMA. 2001 Jan 24-31;285(4):421-9.

PMID:
11242426
15.

The use of prescription charges.

Huttin C.

Health Policy. 1994 Jan 31;27(1):53-73. Review.

PMID:
10133137
16.

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S.

N Engl J Med. 1987 Aug 27;317(9):550-6.

PMID:
3302713

Supplemental Content

Loading ...
Support Center